Comparison of objective response rate and long-term overall survival in patients with treated immune checkpoint inhibitors in metastatic urothelial carcinoma.

Tural, DenizArslan, CagataySelcukbiricik, FatihOlmez, Omer FatihAkar, EmreErman, MustafaUrun, Yuksel2024-05-192024-05-1920230732-183X1527-7755https://hdl.handle.net/20.500.12713/5972Genitourinary Cancers Symposium -- FEB 16-18, 2023 -- ELECTR NETWORK[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keywords]Comparison of objective response rate and long-term overall survival in patients with treated immune checkpoint inhibitors in metastatic urothelial carcinoma.Conference Object41WOS:001098050200510N/A